EUCTR2007-001364-72-CZ进行中（未招募）1 期
ong-term safety follow-up after growth hormone treatment (rhGH) of short children born Small for Gestational Age (SGA)
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- Sandoz GmbH
- 入组人数
- 118
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •1. All patients who fulfilled the diagnosis SGA, participated in study EP00-401, and received at least one dose of study medication
- •2. Written informed patient of patient (for children who can read and/or understand) and/or parent or legal guardian
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 40
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 40
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range 0
排除标准
- •1. Patients unwilling and/or parents/guardians who are not capable of ensuring compliance with the provisions of the study protocol
研究者
相似试验
进行中（未招募）
1 期
ong-term safety follow-up after growth hormone treatment (rhGH) of short children born Small for Gestational Age (SGA)Growth disturbance (current height standard deviation score (SDS) < -2.5 and parental adjusted SDS < -1) in short children born small for gestational age (SGA), with a birth weight and/or length below -2 standard deviation (SD), who failed to show catch-up growth (height velocity (HV) SDS < 0 during the last year) by 4 years of age or laterMedDRA version: 20.0Level: LLTClassification code 10018747Term: Growth hormoneSystem Organ Class: 100000004848EUCTR2007-001364-72-PLSandoz GmbH200
进行中（未招募）
1 期
ong-term safety follow-up after growth hormone treatment (rhGH) ofshort children born Small for Gestational Age (SGA)Growth disturbance (current height standard deviation score (SDS) < -2.5 and parental adjusted SDS < -1) in short children born small for gestational age (SGA), with a birth weight and/or length below -2 standard deviation (SD), who failed to show catch-up growth (height velocity (HV) SDS < 0 during the last year) by 4 years of age or laterMedDRA version: 17.1Level: LLTClassification code 10018747Term: Growth hormoneSystem Organ Class: 100000004848EUCTR2007-001364-72-HUSandoz GmbH200
进行中（未招募）
1 期
ong-term safety follow-up after growth hormone treatment (rhGH) of short children born Small for Gestational Age (SGA)EUCTR2007-001364-72-DESandoz GmbH118
已完成
不适用
Effects of growth hormone treatment after final height in Prader-Willi SyndromePrader Willi SyndromeNutritional, Metabolic, EndocrineDisorders of other endocrine glandsISRCTN24648386Dutch Growth Foundation (Netherlands)20
进行中（未招募）
1 期
Effects of growth hormone treatment after final height in Prader-Willi Syndrome: A double-blind multicenter, cross-over study on the effects of growth hormone versus placebo on body composition and psychosocial behaviour in transition - Effects of GH after final height in PWSPrader-Willi SyndromeMedDRA version: 9.1Level: LLTClassification code 10036476Term: Prader-Willi syndromeEUCTR2007-004716-31-NLDutch Growth Foundation